SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Apollo Hospitals surges on plans to add 500 beds this fiscal

30 Sep 2011 Evaluate

Apollo Hospitals is currently trading at Rs. 519.25, up by 5.60 points or 1.09% from its previous closing of Rs. 513.65 on the BSE.

The scrip opened at Rs. 516.00 and has touched a high and low of Rs. 522.95 and Rs. 512.15 respectively. So far 11244 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 599.00 on 13-Oct-2010 and a 52 week low of Rs. 432.30 on 24-Jun-2011.

Last one week high and low of the scrip stood at Rs. 528.00 and Rs. 507.05 respectively. The current market cap of the company is Rs. 6748.20 crore.

The promoters holding in the company stood at 31.55% while Institutions and Non-Institutions held 37.46% and 29.42% respectively. 

Apollo Hospitals is likely to add 500 beds by the end of this fiscal, taking the total bed strength of the group to over 9,000. In next 24 months the entity is on the track of adding 2,000 beds. Presently, Apollo Hospitals has a capacity of over 8,500 beds across 54 hospitals within and outside India.

The company is also mulling setting up three medical colleges in the next five years as part of the plans to expand its medical education venture. The Chennai-headquartered healthcare chain is already running 11 nursing and hospital management colleges. It has 1,200 pharmacies and over 100 diagnostic clinics across the country.

Recently, Apollo Hospitals introduced a ‘movement disorder clinic’ in Chennai. This clinic is located in the Apollo Hospitals centre in the city, which will provide diagnosis and treatment for patients ailing with chronic disorders such as Parkinson's disease, essential tremor, secondary tremor and Tourette’s syndrome.

Apollo Hospital Ent. Share Price

7699.05 143.10 (1.89%)
17-Apr-2026 16:59 View Price Chart
Peers

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×